y Near-patient SARS-CoV-2 molecular platforms: new-old tools for new-old problems
Open Access
- 1 December 2020
- journal article
- editorial
- Published by Elsevier BV in The Lancet Respiratory Medicine
- Vol. 8 (12), 1161-1163
- https://doi.org/10.1016/S2213-2600(20)30451-3
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective interventional, non-randomised, controlled studyPublished by Elsevier BV ,2020
- Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detectionClinical Microbiology & Infection, 2020
- Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy studyThe Lancet Microbe, 2020
- Covid-19 Molecular Diagnostic Testing - Lessons LearnedNew England Journal of Medicine, 2020
- Point of Care Nucleic Acid Testing for SARS-CoV-2 in Hospitalized Patients: A Clinical Validation Trial and Implementation StudyCell Reports Medicine, 2020
- Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection (Review)Cochrane Database Of Systematic Reviews, 2019
- The Lancet Commission on diagnostics: advancing equitable access to diagnosticsThe Lancet, 2019
- Evaluating Novel Diagnostics in an Outbreak Setting: Lessons Learned from EbolaJournal of Clinical Microbiology, 2017
- Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trialThe Lancet Respiratory Medicine, 2017